Joseph V. Pergolizzi, Jr., MD, MBA

(1) Co-founder & COO (2) Co-founder (3) Co-founder (4) CEO
(1) NEMA (2) Neumentum (3) Enalare (4) Advantx
Naples, Florida

Disclosure information not submitted.

Presentation(s):

• ADV502: Possible Role for Maintenance treatment of (Poly)Substance Use Disorder

  POSTER ABSTRACT

• Sigma Receptor Redux

  POSTER ABSTRACT

• Sigma-1 and Sigma-2 Chaperone-Receptors for Therapeutic Targets

  POSTER ABSTRACT